Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenoma

Autor: Sung Koo Lee, Myung-Hwan Kim, Dongwook Oh, Dong Wan Seo, Tae Jun Song, Dong Hui Cho, Raymond E. Kim, Min Keun Cho, Do Hyun Park, Seunghee Baek, Sang Soo Lee, Kwangwoo Nam
Rok vydání: 2017
Předmět:
Adenoma
Adult
Male
medicine.medical_specialty
Ampulla of Vater
Endoscopic Mucosal Resection
medicine.medical_treatment
Perforation (oil well)
Common Bile Duct Neoplasms
Blood Loss
Surgical
Argon plasma coagulation
Gastroenterology
Risk Assessment
Cohort Studies
Tertiary Care Centers
03 medical and health sciences
fluids and secretions
0302 clinical medicine
Sex Factors
Internal medicine
Republic of Korea
Medicine
Effective treatment
Humans
Radiology
Nuclear Medicine and imaging
Adverse effect
Propensity Score
Aged
Retrospective Studies
Argon Plasma Coagulation
business.industry
Age Factors
biochemical phenomena
metabolism
and nutrition
Middle Aged
medicine.disease
Ablation
Prognosis
Combined Modality Therapy
Treatment Outcome
030220 oncology & carcinogenesis
Ampullary Adenoma
Propensity score matching
Pancreatitis
030211 gastroenterology & hepatology
Female
Patient Safety
business
Zdroj: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 30(4)
ISSN: 1443-1661
Popis: BACKGROUND AND AIM Endoscopic snare papillectomy (ESP) is an effective treatment for ampullary adenoma. Argon plasma coagulation (APC) is widely used as an additional method to control bleeding or ablate the residual tumor. However, the efficacy of this procedure has not yet been fully evaluated. This study aimed to evaluate the usefulness of APC as an additional method to ESP. METHODS Patients who underwent ESP for ampullary adenoma between September 2005 and September 2015 were retrospectively reviewed. Using propensity score matching, we compared short- and long-term outcomes between the ESP-with-additional-APC group (ESP + APC group) and the ESP-only group. Primary outcome was early post-ESP adverse events (AE), and secondary outcomes were late AE and recurrence. RESULTS Among 109 patients, additional APC was carried out in 59 (54.1%) patients. After matching, 41 patients were included in both groups, respectively. Bleeding rate was significantly lower in the ESP + APC group than in the ESP-only group (7.3% vs 31.7%, odds ratio = 0.180, P
Databáze: OpenAIRE
Externí odkaz: